✦ LIBER ✦
Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial
✍ Scribed by François-Xavier Mahon; Delphine Réa; Joëlle Guilhot; François Guilhot; Françoise Huguet; Franck Nicolini; Laurence Legros; Aude Charbonnier; Agnès Guerci; Bruno Varet; Gabriel Etienne; Josy Reiffers; Philippe Rousselot
- Book ID
- 117785487
- Publisher
- The Lancet
- Year
- 2010
- Tongue
- English
- Weight
- 201 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1470-2045
No coin nor oath required. For personal study only.